Race and Colorectal Cancer Disparities: Health-Care Utilization vs Different Cancer Susceptibilities
Authors:
- A. O. LaiyemoALA. O. Laiyemo
- C. DoubeniCDC. Doubeni
- P. F. PinskyPPP. F. Pinsky
- V. P. Doria-RoseVDV. P. Doria-Rose
- R. BresalierRBR. Bresalier
- L. E. LameratoLLL. E. Lamerato
- E. D. CrawfordECE. D. Crawford
- P. KvalePKP. Kvale
- M. FouadMFM. Fouad
- T. HickeyTHT. Hickey
- T. RileyTRT. Riley
- J. WeissfeldJWJ. Weissfeld
- 31 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 102 (8) , 538-546
Abstract
It is unclear whether the disproportionately higher incidence and mortality from colorectal cancer among blacks compared with whites reflect differences in health-care utilization or colorectal cancer susceptibility. A total of 60, 572 non-Hispanic white and black participants in the ongoing Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial underwent trial-sponsored screening flexible sigmoidoscopy (FSG) without biopsy at baseline in 10 geographically dispersed centers from November 1993 to July 2001. Subjects with polyps or mass lesions detected by FSG were referred to their physicians for diagnostic workup, the cost of which was not covered by PLCO. The records of follow-up evaluations were collected and reviewed. We used log binomial modeling with adjustment for age, education, sex, body mass index, smoking, family history of colorectal cancer, colon examination within previous 3 years, personal history of polyps, and screening center to examine whether utilization of diagnostic colonoscopy and yield of neoplasia differed by race. Among 57 561 whites and 3011 blacks who underwent FSG, 13,743 (23.9%) and 767 (25.5%) had abnormal examinations, respectively. A total of 9944 (72.4%) whites and 480 (62.6%) blacks had diagnostic colonoscopy within 1 year following the abnormal FSG screening. When compared with whites, blacks were less likely to undergo diagnostic evaluation (adjusted risk ratio = 0.88, 95% confidence interval = 0.83 to 0.93). Overall, among subjects with diagnostic colonoscopy (n = 10 424), there was no statistically significant difference by race in the prevalence of adenoma, advanced adenoma, advanced pathology in small adenomas (high-grade dysplasia or villous histology in adenomas <10 mm), or colorectal cancer. We observed a lower follow-up for screen-detected abnormalities among blacks when compared with whites but little difference in the yield of colorectal neoplasia. Health-care utilization may be playing more of a role in colorectal cancer racial disparity than biology.Keywords
This publication has 36 references indexed in Scilit:
- Socioeconomic and Racial Patterns of Colorectal Cancer Screening among Medicare Enrollees in 2000 to 2005Cancer Epidemiology, Biomarkers & Prevention, 2009
- Racial Disparities Among Patients With Lung Cancer Who Were Recommended Operative TherapyArchives of Surgery, 2009
- Polyp Size and Advanced Histology in Patients Undergoing Colonoscopy Screening: Implications for CT ColonographyGastroenterology, 2008
- Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White PatientsJAMA, 2008
- Occurrence of Colorectal Adenomas in Younger Adults: An Epidemiologic Necropsy StudyClinical Gastroenterology and Hepatology, 2008
- Secular Trends in Mortality From Common Cancers in the United States by Educational Attainment, 1993–2001JNCI: Journal of the National Cancer Institute, 2008
- Racial Segregation and Disparities in Cancer Stage for SeniorsJournal of General Internal Medicine, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Environmental influences on the high mortality from colorectal cancer in African Americans2007
- Explaining Black–White Differences in Receipt of Recommended Colon Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2005